Brass, Eric P.

Trends in antimicrobial drug development: Implications for the future

Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 867

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

Spellberg, B., Ibrahim, A. S., Chin-Hong, P. V., Kontoyiannis, D. P., Morris, M. I., Perfect, J. R., Fredricks, D., & Brass, E. P. (2012) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 308

Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients

Brass, E. (1995) · Clinical Therapeutics

Dialysis and Renal Disease ManagementClinical Nutrition and Gastroenterology

Cited by 107

Impact on carnitine homeostasis of short-term treatment with the pivalate prodrug cefditoren pivoxil

Brass, E. (2003) · Clinical Pharmacology & Therapeutics

Antibiotics Pharmacokinetics and EfficacyMetabolism and Genetic Disorders

Cited by 50

Pulmonary V̇o2 dynamics during treadmill and arm exercise in peripheral arterial disease

Bauer, T. A., Brass, E. P., Nehler, M., Barstow, T. J., & Hiatt, W. R. (2004) · Journal of Applied Physiology

Cardiovascular and exercise physiologyPeripheral Artery Disease Management

Cited by 41